These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35773715)

  • 1. Loss of tau expression attenuates neurodegeneration associated with α-synucleinopathy.
    Vermilyea SC; Christensen A; Meints J; Singh B; Martell-Martínez H; Karim MR; Lee MK
    Transl Neurodegener; 2022 Jul; 11(1):34. PubMed ID: 35773715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy.
    Singh B; Covelo A; Martell-Martínez H; Nanclares C; Sherman MA; Okematti E; Meints J; Teravskis PJ; Gallardo C; Savonenko AV; Benneyworth MA; Lesné SE; Liao D; Araque A; Lee MK
    Acta Neuropathol; 2019 Oct; 138(4):551-574. PubMed ID: 31168644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment.
    Karim MR; Liao EE; Kim J; Meints J; Martinez HM; Pletnikova O; Troncoso JC; Lee MK
    Mol Neurodegener; 2020 Apr; 15(1):27. PubMed ID: 32299471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prominent microglial inclusions in transgenic mouse models of α-synucleinopathy that are distinct from neuronal lesions.
    Tanriöver G; Bacioglu M; Schweighauser M; Mahler J; Wegenast-Braun BM; Skodras A; Obermüller U; Barth M; Kronenberg-Versteeg D; Nilsson KPR; Shimshek DR; Kahle PJ; Eisele YS; Jucker M
    Acta Neuropathol Commun; 2020 Aug; 8(1):133. PubMed ID: 32787922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.
    Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK
    Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Drp1 Function and Mitochondrial Morphology Are Associated with the α-Synuclein Pathology in a Transgenic Mouse Model of Parkinson's Disease.
    Portz P; Lee MK
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction.
    Gentzel RC; Toolan D; Jinn S; Schachter JB; Ma L; Kahle PJ; Smith SM; Marcus JN
    Neurobiol Aging; 2021 Oct; 106():12-25. PubMed ID: 34225000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils.
    Dhillon JS; Trejo-Lopez JA; Riffe C; Levites Y; Sacino AN; Borchelt DR; Yachnis AY; Giasson BI
    Acta Neuropathol Commun; 2019 May; 7(1):80. PubMed ID: 31109378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble and insoluble lysates from the human A53T mutant α-synuclein transgenic mouse model induces α-synucleinopathy independent of injection site.
    Lee M; Barnes J; Vermilyea S; Meints J; Martinez H
    Res Sq; 2024 Mar; ():. PubMed ID: 38496623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
    Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martínez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; Liao D
    J Neurosci; 2018 Nov; 38(45):9754-9767. PubMed ID: 30249789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy.
    Chatterjee D; Sanchez DS; Quansah E; Rey NL; George S; Becker K; Madaj Z; Steiner JA; Ma J; Escobar Galvis ML; Kordower JH; Brundin P
    J Parkinsons Dis; 2019; 9(2):315-326. PubMed ID: 30932894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.
    Patterson JR; Duffy MF; Kemp CJ; Howe JW; Collier TJ; Stoll AC; Miller KM; Patel P; Levine N; Moore DJ; Luk KC; Fleming SM; Kanaan NM; Paumier KL; El-Agnaf OMA; Sortwell CE
    Neurobiol Dis; 2019 Oct; 130():104525. PubMed ID: 31276792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo.
    Colla E; Coune P; Liu Y; Pletnikova O; Troncoso JC; Iwatsubo T; Schneider BL; Lee MK
    J Neurosci; 2012 Mar; 32(10):3306-20. PubMed ID: 22399753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Templated α-Synuclein Inclusion Formation Is Independent of Endogenous Tau.
    Stoyka LE; Mahoney CL; Thrasher DR; Russell DL; Cook AK; Harris AT; Narayanan A; Janado TP; Standaert DG; Roberson ED; Volpicelli-Daley LA
    eNeuro; 2021; 8(3):. PubMed ID: 33972291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicle trafficking and lipid metabolism in synucleinopathy.
    Fanning S; Selkoe D; Dettmer U
    Acta Neuropathol; 2021 Apr; 141(4):491-510. PubMed ID: 32607605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
    Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
    Henderson MX; Trojanowski JQ; Lee VM
    Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous loss of Engrailed-1 and α-synucleinopathy (En1/SYN): A dual-hit preclinical mouse model of Parkinson's disease, analyzed with artificial intelligence.
    Stetzik L; Mercado G; Steiner JA; Lindquist A; Gilliland C; Schulz E; Meyerdirk L; Smith L; Molina J; Moore DJ
    Neurobiol Dis; 2024 Oct; 200():106647. PubMed ID: 39187209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice.
    Rutherford NJ; Dhillon JS; Riffe CJ; Howard JK; Brooks M; Giasson BI
    Hum Mol Genet; 2017 Dec; 26(24):4906-4915. PubMed ID: 29036344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.